# FDA Inspection 1112567 - Eversight - October 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/eversight/6520eec4-e317-4408-bd0e-96538a671df3
Source feed: FDA_Inspections

> FDA Inspection 1112567 for Eversight on October 25, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1112567
- Company Name: Eversight
- Inspection Date: 2019-10-25
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1112567 - 2019-10-25](https://www.keypedia.com/records/fda_inspections/eversight/4f8bcdbf-ed23-49db-bbad-8a78835b995f)
- [FDA Inspection 1028802 - 2017-09-28](https://www.keypedia.com/records/fda_inspections/eversight/6b1efacf-023e-4475-84eb-4da6391da48d)
- [FDA Inspection 926620 - 2015-05-18](https://www.keypedia.com/records/fda_inspections/eversight/f09dce16-e9b0-489e-8acb-252c093bb2ec)
- [FDA Inspection 805412 - 2012-10-30](https://www.keypedia.com/records/fda_inspections/eversight/31ce0176-9436-470d-b703-ebc52423c69d)
- [FDA Inspection 701363 - 2010-12-14](https://www.keypedia.com/records/fda_inspections/eversight/33fc7a1f-4a2a-4f72-8cf1-9a0f1e864900)

Company: https://www.keypedia.com/companies/eversight/20611d04-9f8e-4cdf-9e14-ce3704efe03f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d